WAF1/CIP1 protein expression in human breast tumors

Breast Cancer Research and Treatment

Volumn 43, Issue 2, 1997, Pages 99-103

  Diab, S G ^a   Yu, Y Y ^a   Hilsenbeck, S G ^a   Allred, D C ^b   Elledge, R M ^a,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Dept of Radiol/Radiation Oncology ^*  (United States)

^c Department of Pathology ^*  (United States)

Author keywords

Breast cancer; Immunohistochemistry; p53 protein; WAF1 CIP1 protein

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P53;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; CYTOPLASM; DISEASE MARKER; EPITHELIUM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STAINING; TUMOR VOLUME;

BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PROGNOSIS; S PHASE; STAINING AND LABELING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030895754     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005752829260     Document Type: Article

References (13)

1. Osborne CK, Yochmowitz MG, Knight WA, McGuire WL: The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46: 2884-2888, 1980
2. Lowe SW, Ruley HE, JacksT, Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993
3. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991
4. El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Khon KW, Elledge SJ, Kinzler KW, Vogelstein B: WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54: 1169-1174, 1994
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
6. Xiong Y, Zhang H, Beach D: Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev 7: 1572-1583, 1993
7. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
8. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391-3395, 1994
9. Shiohara M, El-Deiry WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen DL, Vogelstein B, Koeffler HP: Absence of WAF1 mutations in a variety of human malignancies. Blood 84: 3781-3784, 1994
10. Allred DC, Clark G, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85: 200-206, 1994
11. Wasielewski R, Von WM, Nolte M, Wilkens L, Georgii A: Effects of antigen retrieval by microwave heating in formalin-fixed tissue sections on a broad panel of antibodies. Histochemistry 102: 165-172, 1994
12. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature 351: 453-456, 1991
13. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1345, 1992